Development of probiotic materials for ameliorating stress and type 2 diabetes using microbiome analysis (KAP220383)

High-functionality that can improve or prevent stress and diabetes through cell test, disease model animal efficacy test, pre-clinical test, mass production, optimization, and formulation through the discovery of lactic acid bacteria with excellent suppression of inflammation using microbiome analysis technology To develop and commercialize probiotic materials.